Long-term hematopoietic transfer of the anti-cancer and lifespan-extending capabilities of a genetically engineered blood system by transplantation of bone marrow mononuclear cells
eLife · 2024
DOI: 10.7554/elife.88275 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, 2024. Verfasst von Jing-Ping Wang und 16 weiteren Autor:innen. Beteiligte Einrichtung: The Ph.D. Program in Medicine Neuroscience, Taipei Medical University, Taipei, Taiwan. Hauptthemen laut MEDLINE: Kruppel-Like Transcription Factors, Longevity. Die Arbeit nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chang Gung Memorial Hospital, National Science and Technology Council, Taipei Medical University.
Abstract (Originalsprache)
A causal relationship exists among the aging process, organ decay and disfunction, and the occurrence of various diseases including cancer. A genetically engineered mouse model, termed Klf1 K74R/K74R or Klf1 (K74R), carrying mutation on the well-conserved sumoylation site of the hematopoietic transcription factor KLF1/EKLF has been generated that possesses extended lifespan and healthy characteristics, including cancer resistance. We show that the healthy longevity characteristics of the Klf1 (K74R) mice, as exemplified by their higher anti-cancer capability, are likely gender-, age-, and genetic background-independent. Significantly, the anti-cancer capability, in particular that against melanoma as well as hepatocellular carcinoma, and lifespan-extending property of Klf1 (K74R) mice, could be transferred to wild-type mice via transplantation of their bone marrow mononuclear cells at a young age of the latter. Furthermore, NK(K74R) cells carry higher in vitro cancer cell-killing ability than wild-type NK cells. Targeted/global gene expression profiling analysis has identified changes in the expression of specific proteins, including the immune checkpoint factors PDCD and CD274, and cellular pathways in the leukocytes of the Klf1 (K74R) that are in the directions of anti-cancer and/or anti-aging. This study demonstrates the feasibility of developing a transferable hematopoietic/blood system for long-term anti-cancer and, potentially, for anti-aging.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Ph.D. Program in Medicine Neuroscience, Taipei Medical University, Taipei, Taiwan.
- Institute of Molecular Biology, Academia Sinica, Taipei, Taiwan.
- Chang Gung Memorial Hospital, Keelung, Taiwan.
- Pro-Clintech Co. Ltd, Keelung, Taiwan.
- Department of Nursing, Chang Gung University of Science and Technology, Taoyuan, Taiwan.
- Community Medicine Research Center, Chang Gung Memorial Hospital, Keelung Branch, Keelung, Taiwan.
ORCID-Profile: Chun-Hao Hung, Yu-Chiau Shyu, C-K James Shen
Förderung
- Chang Gung Memorial Hospital
- National Science and Technology Council
- Taipei Medical University
- Academia Sinica
Zitieren
APA
Wang, J. P., Hung, C. H., Liou, Y. H., Liu, C. C., Yeh, K. H., Wang, K. Y., Lai, Z. S., Chatterjee, B., Hsu, T. C., Lee, T. L., Shyu, Y. C., Hsiao, P. W., Chen, L. Y., Chuang, T. J., Yu, C. A., Liao, N. S., & Shen, C. J. (2024). Long-term hematopoietic transfer of the anti-cancer and lifespan-extending capabilities of a genetically engineered blood system by transplantation of bone marrow mononuclear cells. eLife. https://doi.org/10.7554/elife.88275
Vancouver
Wang JP, Hung CH, Liou YH, Liu CC, Yeh KH, Wang KY, et al. Long-term hematopoietic transfer of the anti-cancer and lifespan-extending capabilities of a genetically engineered blood system by transplantation of bone marrow mononuclear cells. eLife. 2024. doi:10.7554/elife.88275
BibTeX
@article{Wang2024,
author = {Wang, Jing-Ping and Hung, Chun-Hao and Liou, Yae-Huei and Liu, Ching-Chen and Yeh, Kun-Hai and Wang, Keh-Yang and Lai, Zheng-Sheng and Chatterjee, Biswanath and Hsu, Tzu-Chi and Lee, Tung-Liang and Shyu, Yu-Chiau and Hsiao, Pei-Wen and Chen, Liuh-Yow and Chuang, Trees-Juen and Yu, Chen-Hsin Albert and Liao, Nan-Shih and Shen, C-K James},
title = {Long-term hematopoietic transfer of the anti-cancer and lifespan-extending capabilities of a genetically engineered blood system by transplantation of bone marrow mononuclear cells},
journal = {eLife},
year = {2024},
doi = {10.7554/elife.88275}
}
EUVIMED